BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$15.27
+19.48%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$32
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.64
- EPS estimate
- -$2.10
- Revenue actual
- $1.5M
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +48.7%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026